Kindly MD, Inc. Reports Material Definitive Agreement

TL;DR

Kindly MD just signed a big financial deal, expect updates.

AI Summary

On October 6, 2025, Kindly MD, Inc. entered into a material definitive agreement, creating a direct financial obligation. The company, incorporated in Utah with its principal office in Salt Lake City, filed this 8-K report on October 7, 2025, detailing these financial obligations.

Why It Matters

This filing indicates Kindly MD, Inc. has entered into a significant financial agreement, which could impact its financial standing and future operations.

Risk Assessment

Risk Level: medium — Entering into material definitive agreements and direct financial obligations can introduce financial risks and uncertainties for a company.

Key Numbers

• 001-42103 — SEC File Number (Identifies the company's filing with the SEC.)
• 84-3829824 — IRS Employer Identification Number (Company's tax identification number.)

Key Players & Entities

• Kindly MD, Inc. (company) — Registrant
• October 6, 2025 (date) — Date of earliest event reported
• October 7, 2025 (date) — Filing date
• Utah (jurisdiction) — State of Incorporation
• Salt Lake City (location) — City of business address

FAQ

Key Financial Figures

• $0.001 — ch Registered Common Stock, par value $0.001 NAKA The Nasdaq Stock Market LLC
• $250,000,000 — ential issuance by the Company of up to $250,000,000 of secured convertible notes, subject i

Filing Documents

• ea0260402-8k_kindly.htm (8-K) — 35KB
• ea026040201ex10-1_kindly.htm (EX-10.1) — 175KB
• ea026040201ex99-1_kindly.htm (EX-99.1) — 17KB
• 0001213900-25-096801.txt ( ) — 473KB
• nakaw-20251006.xsd (EX-101.SCH) — 4KB
• nakaw-20251006_def.xml (EX-101.DEF) — 26KB
• nakaw-20251006_lab.xml (EX-101.LAB) — 36KB
• nakaw-20251006_pre.xml (EX-101.PRE) — 25KB
• ea0260402-8k_kindly_htm.xml (XML) — 6KB

01 - Entry

Item 1.01 - Entry into Material Agreement Antalpha Loan Agreement On October 6, 2025, Naka SPV 2, LLC (the "Company"), a Delaware limited liability company and wholly owned subsidiary of Kindly MD, Inc. ( "Kindly MD"), entered into a Master Loan Agreement, including a loan confirmation thereunder, with Antalpha Digital Pte. Ltd., a private company organized under the laws of Singapore ("Antalpha") (such Master Loan Agreement being referred to as, the "Antalpha Loan Agreement"). The Antalpha Loan Agreement contemplates Antalpha extending a term loan facility in an aggregate principal amount of 206,000,000 USDT (the "Antalpha Loan"), bearing interest at a rate of 7.0% per annum. The Antalpha Loan will be advanced in separate tranches over a period of up to five days to allow for the transfer of collateral from Company to Lender. The first tranche of indebtedness will be equal to an aggregate amount of up to 150,000,000 USDT. The Antalpha Loan will mature thirty days after the date of the extension of the initial tranche. The Company has the option to extend the maturity date for an additional period of 30 days. Amounts advanced under the Antalpha Loan Agreement may not be prepaid during the initial thirty day period, however, should the Company elect to the extend the loan maturity date for an additional thirty days, the loan shall be prepayable without premium or penalty during such optional extension period. The obligations under the Antalpha Loan Agreement are secured solely by Bitcoin or other digital assets agreed to by the Company and Antalpha, and are subject to customary affirmative and negative covenants, loan-to-value requirements, representations and warranties, and events of default. The Company intends to use the proceeds of the Antalpha Loan to satisfy its existing obligations in full under that certain Master Loan Agreement, dated as of September 30, 2025, between the Company and Two Prime Lending Limited, a limited company existing under the laws

01 - Regulation FD Disclosure

Item 7.01 - Regulation FD Disclosure On October 7, 2025, Kindly MD issued a press release announcing the Company's entry into the Antalpha Loan Agreement and, in connection therewith, its non-binding agreement to indicative terms with Antalpha for a potential issuance by the Company of up to $250,000,000 of secured convertible notes, subject in all respects to the negotiation and agreement of definitive documentation. A copy of the press release is attached as Exhibit 99.1 hereto. The information in this Item 7.01 to this Current Report on Form 8-K, and in Exhibit 99.1, furnished herewith, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the " Exchange Act "), or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits (d) Exhibits. Exhibit No. Description of Exhibit 10.1 Loan Agreement dated October 6, 2025 by and between Antalpha Digital Pte. Ltd. and Naka 2 SPV, LLC. 99.1 Press Release dated October 7, 2025. 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL. 1

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunder duly authorized. KINDLY MD, INC. Dated: October 7, 2025 By : /s/ David Bailey David Bailey Chief Executive Officer 2

View Full Filing

View this 8-K filing on SEC EDGAR